Breast Cancer Treatment During Pregnancy: What’s Safe and What to Consider

Breast cancer can often be treated safely during pregnancy, with careful planning to protect both you and your baby. Treatment choices usually mirror standard care but are adjusted for timing and fetal safety. [PM15] Overall, surgery and certain chemotherapy regimens after the first trimester can be feasible, while radiation therapy is typically postponed until after delivery due to fetal risks. [PM15] ^[1]

---

Key Principles

• Aim to treat the cancer effectively while minimizing fetal exposure. This often means planning treatment by trimester and selecting medicines with safer pregnancy profiles. [PM15]
• Use a multidisciplinary team (oncology, maternal–fetal medicine, surgery, neonatology) to tailor timing and modalities to your situation. [PM15]
• Avoid or delay therapies that pose higher fetal risk, such as radiation, especially in early pregnancy. ^[1]

---

What’s Generally Considered Safe

Surgery

• Breast surgery (lumpectomy or mastectomy) is generally safe during pregnancy with adjusted anesthesia and positioning; sentinel node evaluation may be considered with specific tracers to limit fetal exposure. [PM15]

Chemotherapy

• Chemotherapy can be used after the first trimester (usually after 12–14 weeks). Anthracycline-based regimens (like doxorubicin plus cyclophosphamide) have the most established safety data. [PM15]
• Taxanes (paclitaxel/docetaxel) may be considered in the second or third trimester in select high‑risk cases, typically after anthracyclines, with cautious monitoring. Available data suggest no increase in major malformations, but long‑term developmental data are limited. [PM16] [PM13]
• Supportive care (e.g., growth factors) has some pregnancy experience and may be used when benefits outweigh risks under specialist guidance. [PM13]

---

Treatments Commonly Avoided or Delayed

Radiation Therapy

• External breast radiation is generally postponed until after delivery because fetal radiation exposure carries risks like growth restriction and developmental effects that increase with dose. ^[1]
• When absolutely necessary for other cancers, detailed fetal dose calculations are required, but for breast cancer, delaying is standard. ^[1]

Certain Systemic Therapies

• Endocrine therapy (e.g., tamoxifen) and many targeted agents (e.g., trastuzumab) are typically avoided during pregnancy due to known fetal risks such as oligohydramnios and developmental toxicity. [PM15]

---

Timing by Trimester

• First trimester (0–12 weeks): Focus on diagnostic workup and planning; surgery can be performed; chemotherapy is generally avoided due to organ development and higher malformation risk. [PM15]
• Second trimester (13–27 weeks): Surgery and selected chemotherapy are feasible, with close monitoring for maternal blood counts and fetal growth. [PM15]
• Third trimester (28 weeks–delivery): Continue necessary chemotherapy with scheduling to avoid treatment close to delivery; plan delivery timing around treatment cycles when possible. [PM15]

---

Diagnostic Tests

• Ultrasound and mammography with abdominal shielding can be used to evaluate the breast safely during pregnancy. Decisions about MRI depend on contrast use and trimester; gadolinium is generally avoided unless essential. [PM15]

---

Precautions to Protect You and Your Baby

• Treat with standard intent while adjusting timing for fetal safety. This helps maintain cancer control without unnecessary delay. [PM15]
• Start chemotherapy only after the first trimester, and select regimens with the best pregnancy safety data; monitor maternal blood counts and fetal growth regularly. [PM15]
• Postpone radiation therapy until postpartum to avoid fetal exposure; consider surgical options and systemic therapy sequencing instead. ^[1] [PM15]
• Coordinate delivery timing with treatment cycles to reduce infection or bleeding risks at birth; avoid chemotherapy in the 3–4 weeks before delivery when possible. [PM15]
• Use a high‑risk obstetrics clinic for fetal surveillance, including growth ultrasounds and monitoring for preterm labor. [PM15]
• Avoid pregnancy during active cancer treatment not designed for pregnancy, as exposure can harm the embryo or fetus and limit optimal cancer care. ^[2]
• If you previously completed treatment and are now considering pregnancy, waiting at least one year after chemotherapy helps clear potentially damaged eggs, and temporary pauses in endocrine therapy require careful planning and restart after birth or after breastfeeding. ^{[3] [4]}

---

After Treatment and Future Pregnancy

• Pregnancy after completing treatment for early-stage breast cancer does not appear to increase the risk of recurrence or death, but the timing should be individualized based on treatment type and personal risk. ^{[5] [6]}
• Discuss fertility and conception timing with your team, especially if you received chemotherapy or are on endocrine therapy; medicines need time to leave your body before trying to conceive. ^{[7] [8]}

---

Practical Tips

• Ask about trimester‑based treatment plans so you know what is safe now versus later. [PM15]
• Keep all prenatal and oncology appointments for coordinated care and fetal monitoring. [PM15]
• Plan breastfeeding with your team, as some therapies should be avoided during breastfeeding and may need to be resumed after you finish. ^[4]

---

Summary

Many women can safely receive breast cancer treatment during pregnancy with careful adjustments. Surgery is generally safe, chemotherapy is typically started after the first trimester, and radiation is deferred until after delivery to protect the fetus. [PM15] ^[1] Working closely with a multidisciplinary team ensures the best balance between maternal cancer control and fetal safety. [PM15]

---

궁금한 점 있으면 언제든 퍼슬리에 물어보세요.